首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   24933篇
  免费   2355篇
  国内免费   1686篇
耳鼻咽喉   221篇
儿科学   370篇
妇产科学   279篇
基础医学   2790篇
口腔科学   452篇
临床医学   3173篇
内科学   3751篇
皮肤病学   300篇
神经病学   1323篇
特种医学   890篇
外国民族医学   13篇
外科学   2582篇
综合类   4434篇
现状与发展   6篇
一般理论   6篇
预防医学   1851篇
眼科学   629篇
药学   2442篇
  25篇
中国医学   1566篇
肿瘤学   1871篇
  2024年   98篇
  2023年   394篇
  2022年   1028篇
  2021年   1286篇
  2020年   924篇
  2019年   779篇
  2018年   837篇
  2017年   717篇
  2016年   697篇
  2015年   1012篇
  2014年   1179篇
  2013年   1203篇
  2012年   1836篇
  2011年   1888篇
  2010年   1314篇
  2009年   1115篇
  2008年   1441篇
  2007年   1410篇
  2006年   1423篇
  2005年   1234篇
  2004年   972篇
  2003年   980篇
  2002年   850篇
  2001年   662篇
  2000年   656篇
  1999年   545篇
  1998年   329篇
  1997年   289篇
  1996年   233篇
  1995年   247篇
  1994年   191篇
  1993年   110篇
  1992年   179篇
  1991年   153篇
  1990年   111篇
  1989年   95篇
  1988年   100篇
  1987年   84篇
  1986年   67篇
  1985年   57篇
  1984年   37篇
  1983年   27篇
  1982年   19篇
  1981年   17篇
  1980年   18篇
  1979年   31篇
  1977年   16篇
  1973年   11篇
  1972年   10篇
  1971年   9篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
目的 探讨可溶性细胞间粘附分子 1(soluble intercellular adhesion molecule- 1,s ICAM- 1)在妊娠高血压综合征 (简称妊高征 )发病中的作用。 方法 应用酶联免疫吸附法 (EL ISA)测定 6 5例妊高征患者 (妊高征组 ,包括轻度 15例 ,中度 2 4例 ,重度 2 6例 )及 2 5例同期正常妊娠孕妇(对照组 )外周血清中 s ICAM- 1的含量 ;应用化学发光酶联免疫分析法测定两组孕妇血清中白细胞介素 1(interleukin- 1,L I- 1β)及肿瘤坏死因子 (tum or necrosing factor alpha,TNF- α)含量 ;并记录新生儿体重及妊娠结局。 结果 轻、中、重度妊高征组母血清中 s ICAM- 1的含量 [(36 8.5 6± 6 2 .81) μg/L、(6 0 6 .6 3± 10 5 .0 4 ) μg/ L、(85 9.36± 2 0 0 .92 ) μg/ L]均显著高于对照组 [(2 36 .6 9± 96 .33) μg/ L](P<0 .0 5 ,P<0 .0 1,P<0 .0 1) ,中、重度妊高征组母血清中 IL- 1β及 TNF- α的含量均显著高于对照组(P<0 .0 5 ,P<0 .0 1) ;中、重度妊高征组 s ICAM- 1的水平与相应 IL- 1β及 TNF- α的水平呈显著的正相关 (r=0 .6 97,P<0 .0 1;r=0 .74 6 ,P<0 .0 1)。重度妊高征组伴胎儿生长受限 (fetal growth restric-tion,FGR)者血中 s ICAM- 1含量显著高于同组其他孕妇之含量 (P<0 .0 5 )。妊高征组  相似文献   
54.
PURPOSE: Denileukin diftitox is a fusion protein combining diphtheria toxin and interleukin-2 (IL-2) that targets tumor cells expressing the IL-2 receptor. Its efficacy has been shown in CD25+ cutaneous T-cell lymphoma, but not in B-cell non-Hodgkin's lymphoma (NHL). A phase II study was performed to evaluate the efficacy and tolerability of denileukin diftitox for relapsed or refractory B-cell NHL. PATIENTS AND METHODS: Patients with relapsed or refractory B-cell NHL were eligible. Tumor CD25 expression was determined by immunohistochemistry or flow cytometry. Denileukin diftitox was administered intravenously at a dose of 18 microg/kg once daily for 5 days every 3 weeks, up to eight cycles. RESULTS: Of the 45 patients assessable for response, 32 (71%) were refractory to the last chemotherapy treatment, and all were previously treated with rituximab. Three complete responses (6.7%) and eight partial responses (17.8%) were observed, for an overall response rate of 24.5%. Nine patients (20%) had stable disease. Objective response rates were similar in CD25+ (22%) and CD25- histologies (29%), as were stable disease rates (22% and 18%, respectively). For responding patients, the median time to treatment failure was 7 months, with a median follow-up in survivors of 18 months (range, 9 to 28 months), and the projected progression-free survival at 20 months was 24% (95% CI, 0% to 60%). Most toxicities were low-grade and transient. CONCLUSION: Denileukin diftitox seems to be effective in relapsed or refractory, CD25+ and CD25- B-cell NHL and is well-tolerated at the dosage evaluated. Evaluation of denileukin diftitox in combination with other agents may be warranted.  相似文献   
55.
56.
57.
异基因造血干细胞移植并发致死性间质性肺炎   总被引:3,自引:0,他引:3  
目的探讨小儿异基因造血于细胞移植并发间质性肺炎(IP)的发病病因、临床特点、危险因素及防治措施。方法根据尸解病理检查及聚合酶键反应技术对病毒病原学检测结果,结合临床移植资料综合分析。结果14例移植患儿中并发IP3例(3/14),分别死于十19天、+76天、+150天;3例IP中2例移植前后外周血及尸解肺组织直到CMV包涵体;4例3~4应急性GVHD患儿中3例并发IP,10例0~2度急性GVHD无1例并发IP。结论IP是移植早期死亡的重要原因之一,巨细胞病毒感染是IP的主要病原,GVHD严重程度与移植后并发IP密切相关.  相似文献   
58.
The genes coding for separate isoforms of both the human glutathioneS-transferase class mu and class theta enzymes (GSTM1and GSTT1) arepolymorphic with a variable ethnic distribution. These enzymes detoxifyreactive epoxides, including carcinogens produced by tobacco smoke. Becauseof this, the null polymorphism in the GSTM1 gene (coding for the glutathioneS-transferase class mu enzyme) has been studied widely as a possible sourceof inherited susceptibility to smoking-related lung cancer. The more recentlydescribed null polymorphism in the GSTT1 gene also could contribute to anincreased risk of smoking-related lung cancer. As the incidence of lungcancer is known to differ by ethnicity, we have conducted a case-controlstudy in the United States of 108 African-Americans (Blacks) and 60Mexican-Americans (Hispanics) with lung cancer and 132 African-American(Black) and 146 Mexican-American (Hispanic) controls to investigate theassociation of the GSTT1 and GSTM1 polymorphi sms with lung cancer inminority populations. In the unadjusted data, there was a borderlinesignificant association of the GSTM1 null polymorphism with lung cancer inMexican-Americans (odds ratio [OR] = 1.8, 95 percent confidence interval [CI]= 1.0-3.3 ) that was not observed in African-Americans. The GSTT1 nullpolymorphism also had a higher prevalence in cases than controls in bothracial/ethnic groups, but this increase was not statistically significant.When the data were analyzed using logistic regression controlling for age,gender, race, and smoking, no significant association of either trait withlung cancer was observed, with ORs for both traits of approximately 1.3.However, when the prevalence of individuals who were null for bothpolymorphisms was compared by case status, a significant interaction wasobserved. Logistic regression models showed the OR for the association oflung cancer and the presence of both null polymorphisms compared with one(either GSTT1 or GSTM1) or no null genotype to be 2.9 (P < 0.04). Theseresults suggest that there may be carcinogenic intermediates in cigarettesmoke that are substrates for both the GSTT1 and GSTM1 enzymes, and that lungcancer risk is increased more than additively for individuals who have bothGSTT1 and GSTM1 null polymorphisms.  相似文献   
59.
肾上腺素诱导兔血小板聚集的实践与理论探讨   总被引:1,自引:0,他引:1  
目的创建以Adr诱导兔血小板聚集的方法,并对受体分子特性作初步探讨。方法以高K+缓冲液等取代兔PRP中血浆,以Adr诱导聚集,以Apyr证实结果。结果兔血小板悬浮于高K+缓冲液时Adr能单独诱导真正的聚集。结论由此推测血小板膜上α2肾上腺素受体分子可能为由两种亚单位组成:促聚亚单位和辅助亚单位。人辅助亚单位当Adr浓度高达聚集阈值以上时可被激活,与促聚亚单位结合为活性的二聚体,与Adr进一步结合发生聚集作用。兔辅助亚单位则还需要高K+方能被激活  相似文献   
60.
OBJECTIVE: To assess the effect of middle turbinate (MT) and ethmoidal internal wall(EIW) moved externally after microsurgery. METHODS: Twenty-four cases (45 sides) were followed-up endoscopically for (16.3 +/- 9.3) months. Thirteen cases (24 sides) were observed by CT scans. Three cadaver heads were measured for anatomical analysis. RESULTS: Forty-one (91%) of 45 sides obtained better olfactory function after operation. Twenty-two (91%) of 24 sides were found to have better CT changes in sinus ventilation as compared with preoperative CT scans. The gap between the MT and EIW to the orbital wall was (12.0 +/- 1.0) mm, while that between the ethmoidal bulla and processus uncinatus was only (2.3 +/- 0.6) mm as revealed in the autopsy. CONCLUSION: MT and EIW moderately moved suitably to externally had no bad effect on sinus ventilation, and it improved olfaction.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号